Cure8 Ventures I, LP is a venture capital fund based in St. Louis, Missouri. According to its most recent Form D, filed Apr 30, 2020, it has sold $2,900,000 of interests to 7 investors since its first sale in Apr 2019. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Cure8 Ventures GP I, LLC; Tom Siegel.
- Total raised
- $2,900,000Cumulative sales reported on Form D
- Investors
- 7
- First sale
- Apr 1, 2019
- Minimum investment
- None set
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Cure8 Ventures GP I, LLC; Tom Siegel
- Latest Form D
- Apr 30, 2020
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Cure8 Ventures I, LP
What is the minimum investment for Cure8 Ventures I, LP?
Cure8 Ventures I, LP's latest Form D, filed Apr 30, 2020, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Cure8 Ventures I, LP?
Cure8 Ventures I, LP is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has Cure8 Ventures I, LP raised?
Cure8 Ventures I, LP reports $2,900,000 sold from 7 investors on its Form D filed Apr 30, 2020. This is cumulative sales since the offering began, not current assets or performance.
Where is Cure8 Ventures I, LP based?
Cure8 Ventures I, LP is based in St. Louis, Missouri.
When did Cure8 Ventures I, LP launch?
Cure8 Ventures I, LP reports its first sale in Apr 2019.
Size compared with every venture capital fund
Raised more than 62% of the 16 venture capital funds based in Missouri, and more than 76% of all 14,800 that report sales.